Skip to Content

Tag: POCs


Vendors

ResMed exits POC market  

January 8, 2021Liz Beaulieu, Editor

SAN DIEGO – ResMed has ended its three-year foray into the portable oxygen concentrator market due to “market conditions.”  The company says payers and HME providers are relying less on POCs for Stage 2 and Stage 3 COPD patients, dampening demand for the devices.  “ResMed has determined that it can successfully execute its respiratory care strategy and provide the most benefits to patients, HMEs, clinicians and all other stakeholders by reinvesting its...

Mobi, POCs, portable oxygen concentrator, ResMed


Read Full Articlered right arrow icon

Vendors

Inogen expects better second half of 2020

February 28, 2020Liz Beaulieu, Editor

GOLETA, Calif. - Following Inogen's multiple years of high revenue growth, the fourth quarter of 2019 represented a “slowdown,” acknowledges CEO Scott Wilkinson.The company reported revenue of $78.9 million for the fourth quarter of 2019 compared to $86.5 million for the same period in 2018, an 8.8% decrease. It reported a net loss of $1.4 million vs. a net income of $10 million. “We are assessing our organization from both a commercial and operational perspective to identify how...

home oxygen equipment, Inogen, POCs


Read Full Articlered right arrow icon

Vendors

Inogen: Sales issues are largely behind us

November 8, 2019Liz Beaulieu, Editor

GOLETA, Calif. - Inogen officials say they stabilized the business in the third quarter of 2019, after spending the past few quarters right-sizing the company's direct-to-consumer sales force.The company reported DTC sales decreased to $37.8 million in the third quarter compared to $38.3 million for the same period last year, amid a 40% reduction in its sales force for the channel, which was offset by an increase in productivity.“On the direct-to-consumer side, now it's getting back to hiring...

Inogen, POCs


Read Full Articlered right arrow icon

Business Development

Are POCs becoming modality of choice?

May 31, 2019John Andrews

Driven by growing consumer demand, portable oxygen concentrators are becoming more mainstream in the HME industry. And not only are the devices becoming the preferred modality for consumers, they are also being increasingly embraced by physicians and other respiratory clinicians, oxygen market observers say.There are various reasons for the burgeoning growth, but the dominant force seems to be high consumer demand. Patients want these units, said Frank Lazzaro, director of global product management...

3B Medical, Caire, Gas Control Equipment, oxygen therapy, Philips, POCs


Read Full Articlered right arrow icon

Vendors

Inogen's DTC sales shine in Q4

March 1, 2019Liz Beaulieu, Editor

GOLETA, Calif. - 2018 was a “year of investment” for Inogen and it paid off, company officials say, with a 50.4% increase in direct-to-consumer sales in the fourth quarterThe company topped out at 446 inside sales reps for its DTC segment by the end of 2018, a nearly 70% increase compared to 2017.“We feel very comfortable investing in sales capacity, looking at the long-term (potential of the POC market),” said CEO Scott Wilkinson during a conference call to discuss the company's...

Inogen, POCs


Read Full Articlered right arrow icon

Vendors

Reporter's notebook: 2018: The year of DTC, M&A

January 24, 2019Liz Beaulieu, Editor

YARMOUTH, Maine - Two of the most read vendor stories of 2018 concerned Philips (No. 1) and Invacare (No. 5) going direct to cash-paying consumers for their portable oxygen concentrators.That's not surprising, of course. HME providers have been on watch for years for manufacturers tip-toeing into the DTC market, much like Inogen did years ago. But they haven't had anything concrete to go on—until now.Unlike Inogen, Philips and Invacare are only providing POCs direct to cash-paying customers,...

Brightree, home oxygen equipment, Invacare, Philips, POCs, ResMed


Read Full Articlered right arrow icon

Vendors

3B Medical launches Aer

January 18, 2019Liz Beaulieu, Editor

WINTER HAVEN, Fla. - 3B Medical is officially competing for POC business.The company, already established in the sleep therapy market, will start showing and taking orders for its 3B Aer, which weighs in at 4.5 pounds, in February, and plans to start shipping the POCs in March.“It is a competitive market—there will be at least nine manufacturers of POCs starting in February,” said Alex Lucio, CEO. “What does that do? The pricing becomes softer. These units were significantly...

3B Medical, home oxygen, POCs


Read Full Articlered right arrow icon

News

Providers hold off on ordering—for now

December 20, 2018HME News Staff

NEW YORK - The majority of HME providers are reducing or delaying orders for oxygen and CPAP equipment, but that is likely to be temporary, according to a new survey for the fourth quarter of 2018 from Needham & Company.Sixty three percent of respondents said they would reduce or delay orders for oxygen equipment in response to an any willing provider provision set to go into effect Jan. 1 for Medicare, according to the survey of 150 providers.Respondents said they would also reduce or delay orders...

cpap, home oxygen, Needham & Co., POCs


Read Full Articlered right arrow icon

News

Budget neutrality dampens certain oxygen reimbursement

December 19, 2018HME News Staff

WASHINGTON - Reimbursement rates for stationary and portable oxygen concentrators fare quite differently in the 2019 fee schedule, according to an analysis by AAHomecare.The rural rate for stationary concentrators (E1390) will increase 10.9%, from $121.46 to $134.71, and the average regional rate will increase 4.4% from $69.31 to $72.32.The rural rate for POCs (E1392) will decrease 5.2% from $46.77 to $44.32, and the average regional rate will decrease 6.5%, from $38.10 to $35.64.Rates for portable...

aahomecare, budget neutrality, home oxygen, POCs


Read Full Articlered right arrow icon

Vendors

ResMed: Watch for Mobi POC early next year

October 26, 2018Liz Beaulieu, Editor

SAN DIEGO - ResMed is still keeping its plans for the Mobi portable oxygen concentrator largely under wraps.During a conference call on Thursday to discuss ResMed's financial results for the first quarter of fiscal year 2019, CEO Mick Farrell reiterated that the company plans for a “full product launch” in the third quarter, meaning sometime in January-March. He also doubled down on the company's plans to use a “go-to-market” model that focuses on a “full partnership...

Brightree, home oxygen, Mobi, POCs, ResMed


Read Full Articlered right arrow icon